Clinical Trial Update: Effects of Buprenorphine and Naloxone in Opiate Addicts - 4 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating buprenorphine and naloxone in individuals with opioid-related disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Substance Use Disorder

Drugs mentioned

• Naloxone (Naloxone)
• buprenorphine (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 1 | Status: COMPLETED